Chronic Kidney Disease (CKD) is a serious health condition that affects millions of people worldwide. Dialysis is the most common treatment for kidney failure, but it has significant drawbacks, including limited effectiveness, frequent sessions, and various complications. Bio-artificial kidney technology has brought new hope to the field of kidney transplantation. This cutting-edge technology aims to revolutionize kidney health by providing a viable solution for individuals suffering from End-stage Renal Disease (ESRD) and reducing their dependence on traditional dialysis methods. This innovative treatment option has the potential to transform the field and improve patient outcomes on a global scale. Moreover, this innovative technology can lead to cost savings, improved patient outcomes, and enhanced healthcare efficiency. In this review, we summarize the current state of the art of kidney disease management and discuss the development and widespread implementation of this innovative treatment technology.
Gufran et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: